Your session is about to expire
← Back to Search
Other
Healthy for Chronic Obstructive Pulmonary Disease
N/A
Waitlist Available
Led By Marielle Engelen, PhD
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2, 5, 10, 15, 20, 30, 40, 50, 60, 90, 120, 150, 180, 210 and 240 ± 5 minutes
Awards & highlights
Study Summary
For this study a resistance bout will be performed in order to promote the robust response of protein synthesis. Type II muscle fibers often exhibit more atrophy than type I fibers in COPD subjects therefore specifically targeting them in an exercise protocol could have more beneficial outcome for these individuals.
Eligible Conditions
- Chronic Obstructive Pulmonary Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2, 5, 10, 15, 20, 30, 40, 50, 60, 90, 120, 150, 180, 210 and 240 ± 5 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2, 5, 10, 15, 20, 30, 40, 50, 60, 90, 120, 150, 180, 210 and 240 ± 5 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in net whole-body protein synthesis
Secondary outcome measures
24 hour diet recall
Body Composition
Group differences in activity as measured by Physical Activity Scale for the Elderly (PASE)
+11 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: HealthyExperimental Treatment3 Interventions
screening visit: body weight and composition by DXA, height, and vital signs will be assessed.
study day(s): may include combinations of stable isotope infusions with blood draws, acute exercise, cognition testing
Group II: Chronic Obstructive Pulmonary DisorderExperimental Treatment3 Interventions
screening visit: body weight and composition by DXA, height, and vital signs will be assessed.
study day(s): may include combinations of stable isotope infusions with blood draws, acute exercise, cognition testing
Find a Location
Who is running the clinical trial?
Texas A&M UniversityLead Sponsor
140 Previous Clinical Trials
24,016 Total Patients Enrolled
Marielle Engelen, PhDPrincipal InvestigatorTexas A&M University
6 Previous Clinical Trials
246 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger